This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakai, H Articles by Adachi, A Search for Related Content PubMed PubMed Citation Articles by Sakai, H Articles by Adachi, A

Integration is essential for efficient gene expression of human immunodeficiency virus type 1.

Institute for Virus Research, Kyoto University, Japan.

ABSTRACT

A mutant of human immunodeficiency virus type 1 which carries a frameshift insertion in the integrase/endonuclease region of pol gene was constructed in vitro. Upon transfection into cells, although this mutant exhibited a normal phenotype with respect to expression of gag, pol, and env genes and to generation of progeny virions, no replication-competent virus in CD4-positive cells emerged. An assay for the single-step replication of a defective viral genome dependent on trans complementation by rev protein was established and used to monitor the early phase of viral infection process. Viral clones with a mutation in the vif, vpr, or vpu gene displayed no abnormality in the early phase. In contrast, the integrase mutant did not direct a marker gene expression after infection. Together with an observation that the mutant lacked the ability to integrate, these results indicated that the integration was required for efficient viral gene expression and productive infection of human immunodeficiency virus type 1.

This article has been cited by other articles:

• Ho, C.-C., Lin, S.-S., Chou, M.-Y., Chen, F.-L., Hu, C.-C., Chen, C.-S., Lu, G.-Y., Yang, C.-C. (2005). Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J Antimicrob Chemother 56: 372-379 [Abstract] [Full Text]  
• DeHart, J. L., Andersen, J. L., Zimmerman, E. S., Ardon, O., An, D. S., Blackett, J., Kim, B., Planelles, V. (2005). The Ataxia Telangiectasia-Mutated and Rad3-Related Protein Is Dispensable for Retroviral Integration. J. Virol. 79: 1389-1396 [Abstract] [Full Text]  
• Brussel, A., Sonigo, P. (2004). Evidence for Gene Expression by Unintegrated Human Immunodeficiency Virus Type 1 DNA Species. J. Virol. 78: 11263-11271 [Abstract] [Full Text]  
• Bonnenfant, S., Thomas, C. M., Vita, C., Subra, F., Deprez, E., Zouhiri, F., Desmaele, D., d'Angelo, J., Mouscadet, J. F., Leh, H. (2004). Styrylquinolines, Integrase Inhibitors Acting Prior to Integration: a New Mechanism of Action for Anti-Integrase Agents. J. Virol. 78: 5728-5736 [Abstract] [Full Text]  
• Saenz, D. T., Loewen, N., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M., Poeschla, E. M. (2004). Unintegrated Lentivirus DNA Persistence and Accessibility to Expression in Nondividing Cells: Analysis with Class I Integrase Mutants. J. Virol. 78: 2906-2920 [Abstract] [Full Text]  
• Fikkert, V., Van Maele, B., Vercammen, J., Hantson, A., Van Remoortel, B., Michiels, M., Gurnari, C., Pannecouque, C., De Maeyer, M., Engelborghs, Y., De Clercq, E., Debyser, Z., Witvrouw, M. (2003). Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations. J. Virol. 77: 11459-11470 [Abstract] [Full Text]  
• Brussel, A., Sonigo, P. (2003). Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated Provirus. J. Virol. 77: 10119-10124 [Abstract] [Full Text]  
• Van Maele, B., De Rijck, J., De Clercq, E., Debyser, Z. (2003). Impact of the Central Polypurine Tract on the Kinetics of Human Immunodeficiency Virus Type 1 Vector Transduction. J. Virol. 77: 4685-4694 [Abstract] [Full Text]  
• Poon, B., Chen, I. S. Y. (2003). Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA. J. Virol. 77: 3962-3972 [Abstract] [Full Text]  
• Pluymers, W., Pais, G., Van Maele, B., Pannecouque, C., Fikkert, V., Burke, T. R. Jr., De Clercq, E., Witvrouw, M., Neamati, N., Debyser, Z. (2002). Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives. Antimicrob. Agents Chemother. 46: 3292-3297 [Abstract] [Full Text]  
• Vandegraaff, N., Kumar, R., Burrell, C. J., Li, P. (2001). Kinetics of Human Immunodeficiency Virus Type 1 (HIV) DNA Integration in Acutely Infected Cells as Determined Using a Novel Assay for Detection of Integrated HIV DNA. J. Virol. 75: 11253-11260 [Abstract] [Full Text]  
• Vandegraaff, N., Kumar, R., Hocking, H., Burke, T. R. Jr., Mills, J., Rhodes, D., Burrell, C. J., Li, P. (2001). Specific Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Integration in Cell Culture: Putative Inhibitors of HIV-1 Integrase. Antimicrob. Agents Chemother. 45: 2510-2516 [Abstract] [Full Text]  
• Nakajima, N., Lu, R., Engelman, A. (2001). Human Immunodeficiency Virus Type 1 Replication in the Absence of Integrase-Mediated DNA Recombination: Definition of Permissive and Nonpermissive T-Cell Lines. J. Virol. 75: 7944-7955 [Abstract] [Full Text]  
• Bell, P., Montaner, L. J., Maul, G. G. (2001). Accumulation and Intranuclear Distribution of Unintegrated Human Immunodeficiency Virus Type 1 DNA. J. Virol. 75: 7683-7691 [Abstract] [Full Text]  
• Berger, N., Heller, A. E., Störmann, K. D., Pfaff, E. (2001). Characterization of chimeric enzymes between caprine arthritis-encephalitis virus, maedi-visna virus and human immunodeficiency virus type 1 integrases expressed in Escherichia coli. J. Gen. Virol. 82: 139-148 [Abstract] [Full Text]  
• CHEREPANOV, P., PLUYMERS, W., CLAEYS, A., PROOST, P., DE CLERCQ, E., DEBYSER, Z. (2000). High-level expression of active HIV-1 integrase from a synthetic gene in human cells. FASEB J. 14: 1389-1399 [Abstract] [Full Text]  
• Zhu, K., Cordeiro, M. L., Atienza, J., Robinson, W. E. Jr., Chow, S. A. (1999). Irreversible Inhibition of Human Immunodeficiency Virus Type 1 Integrase by Dicaffeoylquinic Acids. J. Virol. 73: 3309-3316 [Abstract] [Full Text]  
• Johnston, J., Power, C. (1999). Productive Infection of Human Peripheral Blood Mononuclear Cells by Feline Immunodeficiency Virus: Implications for Vector Development. J. Virol. 73: 2491-2498 [Abstract] [Full Text]  
• King, P. J., Robinson, W. E. Jr. (1998). Resistance to the Anti-Human Immunodeficiency Virus Type 1 Compound L-Chicoric Acid Results from a Single Mutation at Amino Acid 140 of Integrase. J. Virol. 72: 8420-8424 [Abstract] [Full Text]  
• Farnet, C. M., Wang, B., Hansen, M., Lipford, J. R., Zalkow, L., Robinson, W. E. Jr., Siegel, J., Bushman, F. (1998). Human Immunodeficiency Virus Type 1 cDNA Integration: New Aromatic Hydroxylated Inhibitors and Studies of the Inhibition Mechanism. Antimicrob. Agents Chemother. 42: 2245-2253 [Abstract] [Full Text]  
• Acel, A., Udashkin, B. E., Wainberg, M. A., Faust, E. A. (1998). Efficient Gap Repair Catalyzed In Vitro by an Intrinsic DNA Polymerase Activity of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 72: 2062-2071 [Abstract] [Full Text]  
• Cherepanov, P., Esté, J. A., Rando, R. F., Ojwang, J. O., Reekmans, G., Steinfeld, R., David, G., De Clercq, E., Debyser, Z. (1997). Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1. Mol. Pharmacol. 52: 771-780 [Abstract] [Full Text]  
• Shibagaki, Y., Chow, S. A. (1997). Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection. J. Biol. Chem. 272: 8361-8369 [Abstract] [Full Text]  
• Johnston, M., Hoth, D. (1993). Present status and future prospects for HIV therapies. Science 260: 1286-1293 [Abstract]